May 9 (SeeNews) - Croatian drug maker Belupo has raised its share capital by 50 million kuna ($8.6 million/6.6 million euro) to 204 million kuna by converting a portion of last year's earnings into equity, its parent, Podravka [ZSE:PODR-R-A], said on Thursday.